240 related articles for article (PubMed ID: 15915352)
21. CYP2C8 activity recovers within 96 hours after gemfibrozil dosing: estimation of CYP2C8 half-life using repaglinide as an in vivo probe.
Backman JT; Honkalammi J; Neuvonen M; Kurkinen KJ; Tornio A; Niemi M; Neuvonen PJ
Drug Metab Dispos; 2009 Dec; 37(12):2359-66. PubMed ID: 19773535
[TBL] [Abstract][Full Text] [Related]
22. A new herb-drug interaction of Polygonum cuspidatum, a resveratrol-rich nutraceutical, with carbamazepine in rats.
Chi YC; Lin SP; Hou YC
Toxicol Appl Pharmacol; 2012 Sep; 263(3):315-22. PubMed ID: 22813711
[TBL] [Abstract][Full Text] [Related]
23. Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients.
Ragueneau-Majlessi I; Levy RH; Bergen D; Garnett W; Rosenfeld W; Mather G; Shah J; Grundy JS
Epilepsy Res; 2004 Nov; 62(1):1-11. PubMed ID: 15519127
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.
Fagiolino P; Vázquez M; Maldonado C; Ruiz ME; Volonté MG; Orozco-Suárez S; Lazarowski A
Curr Pharm Des; 2013; 19(38):6701-8. PubMed ID: 23530513
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine markedly raises the plasma concentrations of repaglinide.
Kajosaari LI; Niemi M; Neuvonen M; Laitila J; Neuvonen PJ; Backman JT
Clin Pharmacol Ther; 2005 Oct; 78(4):388-99. PubMed ID: 16198658
[TBL] [Abstract][Full Text] [Related]
26. Metabolism of carbamazepine by CYP3A6: a model for in vitro drug interactions studies.
Mesdjian E; Sérée E; Charvet B; Mirrione A; Bourgarel-Rey V; Desobry A; Barra Y
Life Sci; 1999; 64(10):827-35. PubMed ID: 10096433
[TBL] [Abstract][Full Text] [Related]
27. Time-course of hepatic cytochrome p450 subfamily induction by chronic carbamazepine treatment in rats.
Yamashita H; Kazawa T; Minatogawa Y; Ebisawa T; Yamauchi T
Int J Neuropsychopharmacol; 2002 Mar; 5(1):47-52. PubMed ID: 12057031
[TBL] [Abstract][Full Text] [Related]
28. A single and multiple dose bioavailability study with carbamazepine 400 mg retard tablets with reference to enzyme autoinduction and circadian time differences.
Hoffmann C; Zschiesche M; Franke G; Hoffmann A; Terhaag B; Möritz KU; Siegmund W
Int J Clin Pharmacol Ther; 1997 Nov; 35(11):496-503. PubMed ID: 9401830
[TBL] [Abstract][Full Text] [Related]
29. In vivo evaluation of drug-drug interactions linked to UGT inhibition: the effect of probenecid on dalcetrapib pharmacokinetics.
Aceves Baldó P; Anzures-Cabrera J; Bentley D
Int J Clin Pharmacol Ther; 2013 Mar; 51(3):215-8. PubMed ID: 23357838
[TBL] [Abstract][Full Text] [Related]
30. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
Panesar SK; Bandiera SM; Abbott FS
Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
[TBL] [Abstract][Full Text] [Related]
31. Carbamazepine but not valproate induces bupropion metabolism.
Ketter TA; Jenkins JB; Schroeder DH; Pazzaglia PJ; Marangell LB; George MS; Callahan AM; Hinton ML; Chao J; Post RM
J Clin Psychopharmacol; 1995 Oct; 15(5):327-33. PubMed ID: 8830063
[TBL] [Abstract][Full Text] [Related]
32. The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone.
Tornio A; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2006 Aug; 62(8):645-51. PubMed ID: 16832679
[TBL] [Abstract][Full Text] [Related]
33. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L
Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523
[TBL] [Abstract][Full Text] [Related]
34. Mutual interaction between remacemide hydrochloride and carbamazepine: two drugs with active metabolites.
Leach JP; Blacklaw J; Jamieson V; Jones T; Richens A; Brodie MJ
Epilepsia; 1996 Nov; 37(11):1100-6. PubMed ID: 8917061
[TBL] [Abstract][Full Text] [Related]
35. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.
Eichelbaum M; Tomson T; Tybring G; Bertilsson L
Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637
[TBL] [Abstract][Full Text] [Related]
36. The effect of cannabidiol on the pharmacokinetics of carbamazepine in rats.
Darweesh RS; Khamis TN; El-Elimat T
Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):1871-1886. PubMed ID: 32424477
[TBL] [Abstract][Full Text] [Related]
37. Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers.
Burstein AH; Horton RL; Dunn T; Alfaro RM; Piscitelli SC; Theodore W
Clin Pharmacol Ther; 2000 Dec; 68(6):605-12. PubMed ID: 11180020
[TBL] [Abstract][Full Text] [Related]
38. Effects of poloxamer 407-induced hyperlipidemia on the pharmacokinetics of carbamazepine and its 10,11-epoxide metabolite in rats: Impact of decreased expression of both CYP3A1/2 and microsomal epoxide hydrolase.
Lee YS; Kim YW; Kim SG; Lee I; Lee MG; Kang HE
Eur Neuropsychopharmacol; 2012 Jun; 22(6):431-40. PubMed ID: 22137858
[TBL] [Abstract][Full Text] [Related]
39. Effect of lamotrigine on the pharmacokinetics of carbamazepine and its active metabolite in dogs.
Matar KM; Nicholls PJ; Bawazir SA; Al-Khamis KI; Al-Hassan MI
Eur J Drug Metab Pharmacokinet; 2001; 26(3):149-53. PubMed ID: 11695714
[TBL] [Abstract][Full Text] [Related]
40. Studies on interactions between traditional herbal and Western medicines. IV: lack of pharmacokinetic interactions between Saiko-ka-ryukotsu-borei-to and carbamazepine in rats.
Ohnishi N; Nakasako S; Okada K; Umehara S; Takara K; Nagasawa K; Yoshioka M; Kuroda K; Yokoyama T
Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):129-35. PubMed ID: 11554427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
